Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis-Reference-Cited by-同舟云学术

Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis

Published:2017-02-20 Issue:4 Volume:20 Page:489-496
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Shimojima Yasuhiro¹,Kishida Dai¹,Hineno Akiyo¹²,Yazaki Masahide¹³,Sekijima Yoshiki¹³,Ikeda Shu-ichi¹³

Affiliation:

1. Department of Medicine (Neurology & Rheumatology); Shinshu University School of Medicine; Matsumoto Japan

2. Intractable Disease Care Center; Shinshu University Hospital; Matsumoto Japan

3. Institute for Biomedical Sciences; Shinshu University; Matsumoto Japan

Funder

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.13046/fullpdf

Reference32 articles.

1. Idiopathic hypertrophic pachymeningitis;Kupersmith;Neurology,2004

2. A nationwide survey of hypertrophic pachymeningitis in Japan;Yonekawa;J Neurol Neurosurg Psychiatry,2014

3. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody;Yokoseki;Brain,2014

4. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides;Jennette;Arthritis Rheum,2013

5. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease;Jennette;Nat Rev Rheumatol,2014

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics of hypertrophic cranial pachymeningitis in granulomatosis with polyangiitis: a retrospective single-center study in China;Arthritis Research & Therapy;2024-01-02

2. Quantitative evaluation of the thickened dura mater impacting clinical signs in immune-mediated hypertrophic pachymeningitis;Journal of the Neurological Sciences;2023-10

3. Rituximab for treatment of pachymeningitis in granulomatosis with polyangiitis;BMJ Case Reports;2023-07

4. Hypertrophic pachymeningitis in ANCA-associated vasculitis: Clinical and immunopathological features and insights;Autoimmunity Reviews;2023-06

5. The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review;Biology;2022-12-06